Kuehn Law, PLLC is investigating whether certain officers and directors of Viking Therapeutics, Inc. breached their fiduciary duties through potential self-dealing. This legal inquiry could lead to shareholder damages and corporate governance reforms. Long-term shareholders are encouraged to contact the law firm to protect their rights, as there may be limited time to act. The firm offers free consultations and covers all case costs without charging clients.
The FDA has granted traditional approval to Fabhalta (iptacopan), a first-in-class complement inhibitor, for slowing kidney function decline in adults with primary immunoglobulin A nephropathy (IgAN). Fabhalta showed a 48% slower decline in kidney fu...
Corbin Advisors' Q2 2026 survey shows industrial investor sentiment at its highest in five years, with 84% of participants bullish or neutral-to-bullish due to strong order momentum and demand from data centers and AI sectors. Expectations for Q2 rev...
Ethereum (ETH) has rallied from June lows around $1,500 to nearly $1,950, showing strong short-term bullish momentum. It has moved above its 20-day and 50-day moving averages, which now act as support, but faces resistance at the 100-day EMA near $1,...
Iris Energy's shares fell about 38% as the company pivots from Bitcoin mining to AI-focused data centers, reflecting investor concerns over execution risks like capital needs and operational complexity. Despite the recent drop, the stock remains up n...
Dogecoin (DOGE) remains stuck near recent lows around $0.0737, trading below major moving averages which signals a continuing downtrend. The price faces resistance at $0.0765 and stronger barriers up to $0.1057, making a bullish reversal challenging....
